These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30881500)

  • 1. Isolation of circulating tumor cells and detection of EGFR mutations in patients with non-small-cell lung cancer.
    Zhang Q; Nong J; Wang J; Yan Z; Yi L; Gao X; Liu Z; Zhang H; Zhang S
    Oncol Lett; 2019 Apr; 17(4):3799-3807. PubMed ID: 30881500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sorting and gene mutation verification of circulating tumor cells of lung cancer with epidermal growth factor receptor peptide lipid magnetic spheres.
    Wang SG; Zhang B; Li CG; Zhu JQ; Sun BS; Wang CL
    Thorac Cancer; 2020 Oct; 11(10):2887-2895. PubMed ID: 32856417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of EGFR Mutations in cfDNA and CTCs, and Comparison to Tumor Tissue in Non-Small-Cell-Lung-Cancer (NSCLC) Patients.
    Liu HE; Vuppalapaty M; Wilkerson C; Renier C; Chiu M; Lemaire C; Che J; Matsumoto M; Carroll J; Crouse S; Hanft VR; Jeffrey SS; Di Carlo D; Garon EB; Goldman J; Sollier E
    Front Oncol; 2020; 10():572895. PubMed ID: 33117705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of circulating tumor cells in patients with lung cancer using a rare cell sorter: a pilot study.
    Sugai K; Mori T; Bilal T; Furukawa A; Sekine Y; Kobayashi N; Kikuchi S; Goto Y; Ichimura H; Masuda T; Arai F; Sato Y; Matsusaka S
    BMC Cancer; 2024 Oct; 24(1):1291. PubMed ID: 39425044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Circulating Tumor Cells and EGFR Mutation in Pulmonary Vein and Arterial Blood of Lung Cancer Patients Using a Newly Developed Immunocytology-Based Platform.
    Dejima H; Nakanishi H; Takeyama R; Nishida T; Yamauchi Y; Saito Y; Sakao Y
    Diagnostics (Basel); 2024 Sep; 14(18):. PubMed ID: 39335743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Single-cell detection of EGFR gene mutation in circulating tumor cells in lung cancer].
    Sun S; Deng YL
    Yi Chuan; 2015 Dec; 37(12):1251-7. PubMed ID: 26704950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorter.
    Watanabe M; Kenmotsu H; Ko R; Wakuda K; Ono A; Imai H; Taira T; Naito T; Murakami H; Abe M; Endo M; Nakajima T; Koh Y; Takahashi T
    Cancer Sci; 2018 Aug; 109(8):2539-2548. PubMed ID: 29900633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of EGFR mutations in single cells microdissected from enriched lung tumor cells in peripheral blood.
    Ran R; Li L; Wang M; Wang S; Zheng Z; Lin PP
    Anal Bioanal Chem; 2013 Sep; 405(23):7377-82. PubMed ID: 23828210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly sensitive detection and mutational analysis of lung cancer circulating tumor cells using integrated combined immunomagnetic beads with a droplet digital PCR chip.
    Gao W; Huang T; Yuan H; Yang J; Jin Q; Jia C; Mao G; Zhao J
    Talanta; 2018 Aug; 185():229-236. PubMed ID: 29759193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of circulating tumor cells with chromosomes 7 and 8 polysomy in non-small cell lung cancer and its correlation with epidermal growth factor receptor mutations in cancer tissue].
    Jiang XR; Lu J; Gu YJ; Li YL; Zhao SL; Jin ML
    Zhonghua Bing Li Xue Za Zhi; 2021 May; 50(5):447-452. PubMed ID: 33915649
    [No Abstract]   [Full Text] [Related]  

  • 11. Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer.
    Gasch C; Bauernhofer T; Pichler M; Langer-Freitag S; Reeh M; Seifert AM; Mauermann O; Izbicki JR; Pantel K; Riethdorf S
    Clin Chem; 2013 Jan; 59(1):252-60. PubMed ID: 23136247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR mutation detection of lung circulating tumor cells using a multifunctional microfluidic chip.
    Wang Y; Gao W; Wu M; Zhang X; Liu W; Zhou Y; Jia C; Cong H; Chen X; Zhao J
    Talanta; 2021 Apr; 225():122057. PubMed ID: 33592778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative Mutational Analysis of Circulating Tumor Cells (CTCs) and Plasma-cfDNA Provides Complementary Information for Early Prediction of Relapse: A Pilot Study in Early-Stage Non-Small Cell Lung Cancer.
    Markou AN; Londra D; Stergiopoulou D; Vamvakaris I; Potaris K; Pateras IS; Kotsakis A; Georgoulias V; Lianidou E
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib.
    Punnoose EA; Atwal S; Liu W; Raja R; Fine BM; Hughes BG; Hicks RJ; Hampton GM; Amler LC; Pirzkall A; Lackner MR
    Clin Cancer Res; 2012 Apr; 18(8):2391-401. PubMed ID: 22492982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in
    Pailler E; Faugeroux V; Oulhen M; Mezquita L; Laporte M; Honoré A; Lecluse Y; Queffelec P; NgoCamus M; Nicotra C; Remon J; Lacroix L; Planchard D; Friboulet L; Besse B; Farace F
    Clin Cancer Res; 2019 Nov; 25(22):6671-6682. PubMed ID: 31439588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients.
    Scharpenseel H; Hanssen A; Loges S; Mohme M; Bernreuther C; Peine S; Lamszus K; Goy Y; Petersen C; Westphal M; Glatzel M; Riethdorf S; Pantel K; Wikman H
    Sci Rep; 2019 May; 9(1):7406. PubMed ID: 31092882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lab-on-a-disc platform enables serial monitoring of individual CTCs associated with tumor progression during EGFR-targeted therapy for patients with NSCLC.
    Lim M; Park J; Lowe AC; Jeong HO; Lee S; Park HC; Lee K; Kim GH; Kim MH; Cho YK
    Theranostics; 2020; 10(12):5181-5194. PubMed ID: 32373206
    [No Abstract]   [Full Text] [Related]  

  • 18. Single-Cell Phenotypic and Molecular Characterization of Circulating Tumor Cells Isolated from Cryopreserved Peripheral Blood Mononuclear Cells of Patients with Lung Cancer and Sarcoma.
    Vismara M; Reduzzi C; Silvestri M; Murianni F; Lo Russo G; Fortunato O; Motta R; Lanzoni D; Giovinazzo F; Miodini P; Pasquali S; Suatoni P; Pastorino U; Roz L; Sozzi G; Cappelletti V; Bertolini G
    Clin Chem; 2022 May; 68(5):691-701. PubMed ID: 35304611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of EGFR Mutations in Plasma cfDNA and Paired CTCs of NSCLC Patients before and after Osimertinib Therapy Using Crystal Digital PCR.
    Ntzifa A; Kotsakis A; Georgoulias V; Lianidou E
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34073111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enumeration and Molecular Characterization of Circulating Tumor Cell Using an Epithelial Cell Adhesion Molecule/Vimentin/Epidermal Growth Factor Receptor Joint Capture System in Lung Cancer.
    Jiang W; Wu J; Lin X; Chen Z; Lin L; Yang J
    Clin Med Insights Oncol; 2024; 18():11795549241231568. PubMed ID: 38525298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.